0001062993-23-014168.txt : 20230629
0001062993-23-014168.hdr.sgml : 20230629
20230629162010
ACCESSION NUMBER: 0001062993-23-014168
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230627
FILED AS OF DATE: 20230629
DATE AS OF CHANGE: 20230629
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blackwell Kimberly
CENTRAL INDEX KEY: 0001816465
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40498
FILM NUMBER: 231057664
MAIL ADDRESS:
STREET 1: C/O ZENTALIS PHARMACEUTICALS, LLC
STREET 2: 530 SEVENTH AVENUE, SUITE 2201
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Century Therapeutics, Inc.
CENTRAL INDEX KEY: 0001850119
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 842040295
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25 N 38TH STREET, 11TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: 215-981-4000
MAIL ADDRESS:
STREET 1: 25 N 38TH STREET, 11TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0407
4
2023-06-27
0001850119
Century Therapeutics, Inc.
IPSC
0001816465
Blackwell Kimberly
C/O CENTURY THERAPEUTICS, INC.
25 N 38TH STREET, 11TH FLOOR
PHILADELPHIA
PA
19104
1
0
0
0
0
Stock Option (right to buy)
3.19
2023-06-27
4
A
0
44000
0.00
A
2024-06-27
Common Stock
44000
44000
D
The option vests on the earlier of (a) June 27, 2024, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date.
/s/ Michael Diem, Attorney-in-Fact
2023-06-29